Warning over slimming product after “fatal adverse reactions”

The Spanish Agency for Medicines and Health Products (AEMPS), has issued a warning over the use of a particular slimming product after “fatal adverse reactions”.

ACCORDING to AEMPS, the product called Li Da Daidaihua, “illegally” sold on the Internet is “a danger to the health of consumers”.

The Spainsh agency claims that, although it is presented as a “natural” and “supposedly safe” product, in reality it is not.

AEMPS warns the product contains an active principle, sibutramine, which is not declared on its labeling and which has been prohibited since 2010.

“This substance produces an increase in heart rate and blood pressure that can cause arrhythmias, ischemic heart disease and serious vascular accidents”, said the agency.

AEMPS is working to have the slimming product removed from websites and is asking consumers not to buy or use it “as there have been cases of fatal adverse reactions”, most recently a woman.

Health authorities in Australia and the US have also warned of the risks of Li Da Daidaihua.


Thank you for taking the time to read this news article “Warning over slimming product after “fatal adverse reactions””. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

Author badge placeholder
Written by

Tara Rippin

Tara Rippin is a reporter for Spain’s largest English-speaking newspaper, Euro Weekly News, and is responsible for the Costa Blanca region.
She has been in journalism for more than 20 years, having worked for local newspapers in the Midlands, UK, before relocating to Spain in 1990.
Since arriving, the mother-of-one has made her home on the Costa Blanca, while spending 18 months at the EWN head office in Fuengirola on the Costa del Sol.
She loves being part of a community that has a wonderful expat and Spanish mix, and strives to bring the latest and most relevant news to EWN’s loyal and valued readers.

Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments